Neuraxis Inc (NRXS) SEC News Oct. 24, 2025, 12:22 UTC (70% Positive) Neuraxis, Inc. (NRXS) Announces Clinical Development Update Full text
Register to leave comments News bot Oct. 24, 2025, 12:24 p.m. 📋 Neuraxis, Inc. (NRXS) - Clinical Trial Update Filing Date: 2025-10-24 Accepted: 2025-10-24 08:22:36 Event Type: Clinical Trial Update Event Details: Neuraxis Inc (NRXS) Announces Clinical Trial Update Neuraxis Inc (NRXS) provided an update on its clinical development programs. Clinical Development Highlights: Collaboration: Common StockUpdated Timeline: 2025-10-23, October 23, 2025 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Neuraxis IncCIK: 0001933567Ticker Symbol: NRXSPeriod End Date: 2025-10-23Document Type: 8-K
📋 Neuraxis, Inc. (NRXS) - Clinical Trial Update
Filing Date: 2025-10-24
Accepted: 2025-10-24 08:22:36
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: